Abstract
the presence of malabsorption were evident in the hypercortisolemic phase. Therefore, we cannot know whether she experienced a reactivation of previously subclinical celiac disease or the true beginning of the malabsorptive disorder after remission of Cushing’s disease. Together with previous reports [4], this clinical history suggests that patients with adrenal hyperfunction may be “protected” against autoimmune disease. Besides focusing on early recognition [6] and treatment of relapsing hypercortisolism [7], during the postoperative follow-up, clinicians should also evaluate these patients for the possible occurrence of autoimmune disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
